Speaker illustration

Doctor Hirohisa Endo

Juntendo University School of Medicine, Tokyo (Japan)

Long-term predictive value of high sensitivity c-reactive protein for cancer mortality in patients undergoing percutaneous coronary intervention

Event: ESC Congress 2018

Topic: Cardio-Oncology

Session: Cardiovascular events in malignancies: from prediction to prevention


Differing efficacy of beta blockers on long-term clinical outcomes between ischemic heart failure patients with reduced and mid-range ejection fraction following percutaneous coronary intervention.

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Chronic heart failure – Treatment


Persistent higher high sensitivity C-reactive protein after percutaneous coronary intervention (PCI) predicts higher mortality in patients undergoing PCI with stable coronary artery disease.

Event: ESC Congress 2017

Topic: Risk scores

Session: Risk estimation in high risk individuals


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb